James Loerop serves as Executive at Anika Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, James Loerop has executed 16 insider transactions totaling $203.0K, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 3, 2026 involved exercising options for 20,875 shares valued at $0.
James Loerop currently holds 62,625 shares of Anika Therapeutics, Inc. (ANIK), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James Loerop has been a net seller of ANIK stock. They have purchased $100.0K and sold $103.0K worth of shares.
James Loerop's most recent insider trade was on Feb 3, 2026, when they sold 20,875 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $3.47 |
| Discretionary |
| Feb 3, 2026 | ACRS | $0 | Option Exercise | 20,875 | $N/A | Discretionary |
| Feb 1, 2025 | ACRS | $39.6K | Payment | 15,980 | $2.48 | Discretionary |
| Feb 1, 2024 | ACRS | $4.6K | Payment | 3,853 | $1.20 | Discretionary |
| Feb 1, 2024 | ACRS | $0 | Option Exercise | 11,250 | $N/A | Discretionary |
| Feb 1, 2024 | ACRS | $3.1K | Payment | 2,568 | $1.20 | Discretionary |
| Feb 1, 2024 | ACRS | $0 | Option Exercise | 7,500 | $N/A | Discretionary |
| Aug 28, 2023 | ACRS | $100.0K | Purchase | 14,705 | $6.80 | Discretionary |
| Feb 8, 2023 | ACRS | $59.3K | Sale | 4,267 | $13.89 | Discretionary |
| Feb 1, 2023 | ACRS | $0 | Option Exercise | 11,250 | $N/A | Discretionary |
| Jul 8, 2021 | ANIK | $31.6K | Payment | 731 | $43.24 | Discretionary |
| Jul 8, 2021 | ANIK | $0 | Option Exercise | 3,000 | $N/A | Discretionary |
| Feb 25, 2021 | ANIK | $0 | Option Exercise | 1,567 | $N/A | Discretionary |
| Jul 9, 2020 | ANIK | $43.7K | Sale | 1,244 | $35.15 | Discretionary |
| Jul 8, 2020 | ANIK | $0 | Award | 3,000 | $N/A | Discretionary |